Navigation Links
Endo Cinch Extreme Atraumatic

ProductsEndo Cinch Extreme Atraumatic
Company Encision
Item Endo Cinch Extreme Atraumatic
Features 
  • AEM Laparoscopic Instrument
  • Reusable Insert
  • Protective Shield
  • Primary Insulation Layer
  • Outer Insulation
  • Active Electrode Element
  • Description The 5mm AEM Laparoscopic Instruments incorporate a layered design unique in the industry. AEM Instruments are shielded and monitored to prevent stray electrosurgical burns along the shaft of the instrument caused by insulation failure or capacitive coupling; a well-documented patient safety risk. The protective shield built into all AEM Instruments provides a neutral return path for capacitively coupled energy and protection from insulation failure. The shield is continuously monitored during surgery which provides continuous assurance of the integrity of the instrument.

    Encision has a full line of AEM Surgical Instruments that are equivalent in function, ergonomics, size, shape, length and tip-styles as the conventional instruments that surgeons commonly use ... but with the added assurance of patient safety.
    Info Encision
    Customer Service: (303) 444-2600
    Web site: http://www.encision.com/

    Related medicine products :

    1. Atraumatic Phaco Fixation Ring, 12mm Diameter
    2. Atraumatic Phaco Fixation Ring
    3. Short Atraumatic Grasper
    4. Atraumatic Grasper
    5. Atraumatic Endo- Clinch Grasper
    6. Atraumatic Spring Jaw Babcock Forceps
    7. Atraumatic Grasping Forceps
    8. Graspers Atraumatic
    9. Perc NCircle® Rapid Atraumatic PCNL Stone Extractor
    10. Atraumatic Grasping Forceps (Fallopian), dual-incision
    Breaking Medicine Technology:Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Vivakor Announces New Acquisition Strategy 2Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 1YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 2YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 3YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 4YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 5YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 6U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 1U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 2U S FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U S Bridge to Transplant Clinical Trial 5241 3New Hampshire Rx Card Launching Statewide 5239 1New Hampshire Rx Card Launching Statewide 5239 2